Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant vaccination with Stamaril and FSME Immun or Ixiaro
2017-002137-32Phase 2Completed
- Sponsor
- Hans-Gustaf Ljunggren
- Start
- Jul 2017
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of 17D yellow fever vaccine, FSME-IMMUN and Japanese encephalitis inactivated vaccine in yellow fever, tick-borne encephalitis (TBE) and Japanese encephalitis (JE) (4 arms), sponsored by Hans-Gustaf Ljunggren. Primary endpoint: Immunological response enhancement with concomitant vaccination. Started Jul 2017; status: completed.
02
Drugs
17D yellow fever vaccineFSME-IMMUNJapanese encephalitis inactivated vaccine
03
Conditions
yellow fevertick-borne encephalitis (TBE)Japanese encephalitis (JE)
Beyond the preview
Go deeper on 2017-002137-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002137-32.